Results 251 to 260 of about 484,484 (318)

Hepatitis B virus infection after immunization: How serious it is? An updated review. [PDF]

Clin Exp Med
Marjani A, Alavian SM, Nassiri Toosi M, Alavian SH, Abazari MF, Khamseh A, Jazayeri SM.   +6 more
europepmc   +1 more source

Contactless Conductivity Detection for Capillary Electrophoresis—Developments From 2020 to 2024

ELECTROPHORESIS, EarlyView.
ABSTRACT The review covering the development of capillary electrophoresis with capacitively coupled contactless conductivity detection from 2020 to 2024 is the latest in a series going back to 2004. The article considers applications employing conventional capillaries and planar lab‐on‐chip devices as well as fundamental and technical developments of ...
Peter C. Hauser, Pavel Kubáň
wiley   +1 more source

Chronic Hepatitis B Virus Infection and HLA Variations in a Greek Population. [PDF]

Viruses
Myserli E, Goulis I, Fylaktou A, Exindari M, Minti F, Chatzika G, Iliopoulou E, Agorastou P, Papagiouvanni I, Oikonomou T, Gioula G.   +10 more
europepmc   +1 more source

Electrochemical sensing strategies for on‐site testing of pathogenic nucleic acids

Electrochemical Science Advances, EarlyView.
Abstract Rapid and reliable on‐site pathogen testing is crucial for diagnosing and managing human health. Nucleic acids (NAs) containing genetic information are valuable target molecules for pathogen testing, and sensitive and rapid detection of NAs using electrochemical approaches has been intensively investigated.
Yusuke Kanno, Shuzo Masui, Yusuke Ota, Ryoichi Saito, Takasi Nisisako   +4 more
wiley   +1 more source

HBsAg and anti-HBs coexistence in patients with HBV in acute and chronic phases. [PDF]

Virus Res
Pu Z, Ji Z, Su H, Fu T, Shao Z, Yan Y.
europepmc   +1 more source

Exploring the Potential and Advancements of Circular RNA Therapeutics

Exploration, EarlyView.
Given the remarkable advantages in terms of stability, sustained expression profile, safety, wide range of druggable targets, scalable and cost‐effective manufacturing capabilities, circRNA is currently undergoing intensive investigation for various therapeutic applications such as vaccines, protein replacement, genetic disease treatment, gene therapy,
Lei Wang, Lianqing Wang, Chunbo Dong, Jialong Liu, Guoxin Cui, Shan Gao, Zhida Liu   +6 more
wiley   +1 more source

A Novel Nomogram Model for Predicting the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection. [PDF]

J Hepatocell Carcinoma
Wu Y, Wang M, Zhang Z, Chen G, Zhang B.
europepmc   +1 more source

Emerging Target Discovery Strategies Drive the Decoding of Therapeutic Power of Natural Products and Further Drug Development: A Case Study of Celastrol

Exploration, EarlyView.
Using celastrol as a case study, this review summarizes various target discovery strategies for natural products, including chemical proteomics, protein microarray, degradation‐based protein profiling, proteome‐wide label‐free approaches, network pharmacology, target‐based drug screening, and indirect strategies.
Yanbei Tu, Guiyu Dai, Yanyan Chen, Lihua Tan, Hanqing Liu, Meiwan Chen   +5 more
wiley   +1 more source

RETRACTION: Pyoderma Gangrenosum at Multiple Sites in a Post-Colostomy Ulcerative Colitis Patient With Chronic Hepatitis B Virus: A Case Report. [PDF]

Int Wound J
europepmc   +1 more source

Cardiometabolic Comorbidities in Patients With Chronic Hepatitis B and Impact on Incidence of Liver Complications. A Danish Nationwide Cohort Study. [PDF]

Int J Gen Med
Jespersen S, Bollerup S, Madsbad S, Krogh-Madsen R, Byberg S, Weis N, DANHEP group.   +6 more
europepmc   +1 more source